0001181431-13-017867.txt : 20130319 0001181431-13-017867.hdr.sgml : 20130319 20130319171350 ACCESSION NUMBER: 0001181431-13-017867 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130315 FILED AS OF DATE: 20130319 DATE AS OF CHANGE: 20130319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Khattar Jack A. CENTRAL INDEX KEY: 0001539937 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 13702636 MAIL ADDRESS: STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC. STREET 2: 1550 EAST GUDE DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 1550 E GUDE DR CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 1550 E GUDE DR CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 rrd374289.xml X0306 4 2013-03-15 0 0001356576 SUPERNUS PHARMACEUTICALS INC SUPN 0001539937 Khattar Jack A. C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE ROCKVILLE MD 20850 1 1 0 0 President, CEO Common Stock 2013-03-15 4 P 0 10000 6.1461 A 412058 D Common Stock 1125000 I By the KBT Trust Employee Stock Option (Right to Buy) 7.90 2023-02-05 Common Stock 300000 300000 D Stock Appreciation Right 7.90 2023-02-05 Common Stock 92000 92000 D The option and the stock appreciation rights vest in four equal annual installments beginning on February 5, 2014. The reported purchase was made pursuant to a pre-arranged program for buying stock adopted on December 27, 2012, pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.13 to $6.20, inclusive. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. /s/ Gregory S. Patrick, as attorney-in-fact 2013-03-19